Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy
Article in Future Oncology (August 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Future Oncology (August 2024)
Article in Frontiers in Immunology (March 2024)
Article in Cancers (November 2023)